Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ASTH | TRLV |
|---|---|---|
| Price | $36.81 | $10.65 |
| Change today | ▲ 2.59% | ▼ 0.65% |
| Market cap | $2.05B | $2.05B |
| Return, 3 months | -21.7% | +19.3% |
| Return, year to date | +48.4% | +22.6% |
| Return, 1 year | +27.5% | +20.3% |
| P/E (TTM) | 44.9 | -4.3 |
| P/B | 2.5 | 2.7 |
| P/E percentile vs own 5y | – | 43rd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +41.3% | +67.2% |
| Analyst buy share | 89% | 100% |
| RSI (14) | 51 | 41 |
| 30-day volatility | 45.7% | 60.8% |
| Max drawdown, 1 year | -46.4% | -54.4% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
